tiprankstipranks
Trending News
More News >
Advertisement
Advertisement
Closing Bell Movers:  Stitch Fix slips 4% despite earnings beat
PremiumThe FlyClosing Bell Movers: Stitch Fix slips 4% despite earnings beat
21d ago
KalVista announces $110M convertible senior notes offering
Premium
The Fly
KalVista announces $110M convertible senior notes offering
21d ago
KalVista announces EC, Swissmedic approval for Ekterly
Premium
The Fly
KalVista announces EC, Swissmedic approval for Ekterly
27d ago
Promising Market Penetration and Growth Potential for KalVista Pharmaceuticals’ Ekterly
PremiumRatingsPromising Market Penetration and Growth Potential for KalVista Pharmaceuticals’ Ekterly
1M ago
KalVista Pharmaceuticals’ Earnings Call Highlights EKTERLY Success
Premium
Company Announcements
KalVista Pharmaceuticals’ Earnings Call Highlights EKTERLY Success
1M ago
Promising Outlook for KalVista Pharmaceuticals: Buy Rating Justified by Strong Launch Metrics and Strategic Initiatives for Ekterly
Premium
Ratings
Promising Outlook for KalVista Pharmaceuticals: Buy Rating Justified by Strong Launch Metrics and Strategic Initiatives for Ekterly
1M ago
KalVista Pharmaceuticals: A Promising Investment with Ekterly’s Market Potential
PremiumRatingsKalVista Pharmaceuticals: A Promising Investment with Ekterly’s Market Potential
1M ago
KALV Earnings Report this Week: Is It a Buy, Ahead of Earnings?
Premium
Pre-Earnings
KALV Earnings Report this Week: Is It a Buy, Ahead of Earnings?
1M ago
KalVista Pharmaceuticals Updates Stockholder Meeting Schedule
Premium
Company Announcements
KalVista Pharmaceuticals Updates Stockholder Meeting Schedule
2M ago

Trending

Name
Price
Price Change
S&P 500
Dow Jones
Nasdaq 100